Center for Genetic Epidemiology and Bioinformatics (GeneBio)genebio.phhp.ufl.edu
Wet + dry lab~22 people
Analyzes WGS, WES, EWAS, RNA-seq, lipidomics, metabolomics and metagenomics with statistical and bioinformatics methods. Applies them to aging and age-related diseases in large-scale human populations.
Funded by NIH, UF Office of Research +1 more
›
NIH · active
“Funding Agency: NIH”
UF Office of Research · active
“Funding Agency: UF Office of Research”
NSF, Division of Mathematical Sciences (DMS) · active
“Funding Agency: NSF Division of Mathematical Sciences (DMS)”
GWAS and eQTL mapping, Machine learning and deep learning, TET-assisted bisulfite sequencing, Targeted methylation sequencing, 3D brain organoids and human iPSCs, External exposome-wide association studies
Applies computational and statistical methods to protein sequences, multiple sequence alignments and clinical genetic cohorts. Studies rare human diseases, variant pathogenicity and medical phenotypes.
144 papers since 2024
›
Data Release 1 of the Dark Energy Spectroscopic Instrument
The Astronomical Journal, 2026
The Early Data Release of the Dark Energy Spectroscopic Instrument
The Astronomical Journal, 2024
Validation of the Scientific Program for the Dark Energy Spectroscopic Instrument
Develops statistical and deep-learning methods for single-cell DNA-seq, RNA-seq, ATAC-seq and spatial omics. Targets personalized medicine for cancer and other common complex diseases.
16 papers since 2024
›
Innate immune training in the neonatal response to sepsis
Molecular Medicine, 2025
Multimodal functional deep learning for multiomics data
Briefings in Bioinformatics, 2024
Spatial pattern and differential expression analysis with spatial transcriptomic data
Funded by NATL INST OF HLTH NIGMS, NATL INST OF HLTH NCI +5 more
›
NATL INST OF HLTH NIGMS, Renewal: Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology · August 1, 2026
“Renewal: Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology August 1, 2026 Active Funding: NATL INST OF HLTH NIGMS”
NATL INST OF HLTH NCI, Modulation of Therapeutic Response in Lung Cancer by Tumor Suppressor LKB1 · July 1, 2026
“Modulation of Therapeutic Response in Lung Cancer by Tumor Suppressor LKB1 July 1, 2026 Active Funding: NATL INST OF HLTH NCI”
NATL INST OF HLTH NIGMS, The Role of Brain-Bone Marrow-Gut Interaction following Major Trauma · September 10, 2024
“The Role of Brain-Bone Marrow-Gut Interaction following Major Trauma September 10, 2024 Active Funding: NATL INST OF HLTH NIGMS”